On Weds, April 13th we held a virtual roundtable discussion entitled “Pulmonary Fibrosis and Lung Transplant: Frequently Asked Questions.” This event was hosted by the American Thoracic Society (ATS) was presented as part of the “Lung Disease Week at the ATS” initiative – a program designed to facilitate information exchange between patients and experts on matters relating to lung and airway disorders. This roundtable discussion was a collaborative effort between the ATS Public Advisory Roundtable (PAR), the Pulmonary Fibrosis Foundation.
The panel included experts Steven D. Nathan, MD, FCCP of Inova Fairfax Hospital and Kamyar Afshar, DO of University of California at San Diego. Other discussants were Jennifer Mefford, Vice President of Corporate Partnerships, at the Pulmonary Fibrosis Foundation.
